| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.4 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.041 | 0.5 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.5 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |